“We today occupy the position of world leaders in the field of molecular diagnostic tests for blood cancer”

Ipsogen, based in Marseilles (Luminy) and specializing in cancer profiling, recently merged with Qiagen, the world leader in assay technologies and listed on the NASDAQ, a resounding success for this still-young company. Vincent Fert, co-founder and CEO of Ipsogen, gives his views on this phenomenal growth that never seems to end!